136 related articles for article (PubMed ID: 8736932)
1. Immunogold localization of adhalin, alpha-dystroglycan and laminin in normal and dystrophic skeletal muscle.
Cullen MJ; Walsh J; Roberds SL; Campbell KP
Biochem Soc Trans; 1996 May; 24(2):274S. PubMed ID: 8736932
[No Abstract] [Full Text] [Related]
2. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.
Jones KJ; Kim SS; North KN
J Med Genet; 1998 May; 35(5):379-86. PubMed ID: 9610800
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural localization of adhalin in normal murine skeletal myofiber.
Wakayama Y; Inoue M; Murahashi M; Shibuya S; Jimi T; Kojima H; Oniki H
Ann Neurol; 1996 Feb; 39(2):217-23. PubMed ID: 8967753
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle.
Cullen MJ; Walsh J; Roberds SL; Campbell KP
Neuropathol Appl Neurobiol; 1996 Feb; 22(1):30-7. PubMed ID: 8866780
[TBL] [Abstract][Full Text] [Related]
5. Electron microscopic observations of triple immunogold labelling for dystrophin, beta-dystroglycan and adhalin in human skeletal myofibers.
Inoue M; Wakayama Y; Murahashi M; Shibuya S; Jimi T; Kojima H; Oniki H
Acta Neuropathol; 1996 Dec; 92(6):569-75. PubMed ID: 8960314
[TBL] [Abstract][Full Text] [Related]
6. Dystrophin and the dystrophin-associated glycoprotein, beta-dystroglycan, co-localize in photoreceptor synaptic complexes of the human retina.
Drenckhahn D; Holbach M; Ness W; Schmitz F; Anderson LV
Neuroscience; 1996 Jul; 73(2):605-12. PubMed ID: 8783274
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects.
Handa V; Mital A; Gupta M; Goyle S
Neurol India; 2001 Mar; 49(1):19-24. PubMed ID: 11303236
[TBL] [Abstract][Full Text] [Related]
8. Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy.
Fadic R; Sunada Y; Waclawik AJ; Buck S; Lewandoski PJ; Campbell KP; Lotz BP
N Engl J Med; 1996 Feb; 334(6):362-6. PubMed ID: 8538707
[No Abstract] [Full Text] [Related]
9. Basal lamina abnormality in the skeletal muscle of Walker-Warburg syndrome.
Vajsar J; Ackerley C; Chitayat D; Becker LE
Pediatr Neurol; 2000 Feb; 22(2):139-43. PubMed ID: 10738921
[TBL] [Abstract][Full Text] [Related]
10. Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopy.
Wakayama Y; Inoue M; Kojima H; Murahashi M; Shibuya S; Oniki H
Microsc Res Tech; 2001 Nov; 55(3):154-63. PubMed ID: 11747090
[TBL] [Abstract][Full Text] [Related]
11. Costameric distribution of beta-dystroglycan (43 kDa dystrophin-associated glycoprotein) in normal and dystrophin-deficient human skeletal muscle.
Herrmann R; Anderson LV; Voit T
Biochem Soc Trans; 1996 May; 24(2):501-6. PubMed ID: 8736792
[No Abstract] [Full Text] [Related]
12. Ultrastructural localization of alpha-, beta- and gamma-sarcoglycan and their mutual relation, and their relation to dystrophin, beta-dystroglycan and beta-spectrin in normal skeletal myofiber.
Wakayama Y; Inoue M; Kojima H; Murahashi M; Shibuya S; Jimi T; Hara H; Oniki H
Acta Neuropathol; 1999 Mar; 97(3):288-96. PubMed ID: 10090677
[TBL] [Abstract][Full Text] [Related]
13. Laminin-alpha2 (merosin), beta-dystroglycan, alpha-sarcoglycan (adhalin), and dystrophin expression in congenital muscular dystrophies: an immunohistochemical study.
ter Laak HJ; Leyten QH; Gabreëls FJ; Kuppen H; Renier WO; Sengers RC
Clin Neurol Neurosurg; 1998 Mar; 100(1):5-10. PubMed ID: 9637197
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy.
Ishii H; Hayashi YK; Nonaka I; Arahata K
Neuromuscul Disord; 1997 May; 7(3):191-7. PubMed ID: 9185184
[TBL] [Abstract][Full Text] [Related]
15. Altered distribution of beta-dystroglycan in sarcolemma of human dystrophic muscles: an immunohistochemical study.
Jimi T; Wakayama Y; Takeda A; Kobayashi T; Kumagai T; Suzuki Y; Hasegawa O; Yamashita S; Shibuya S; Kuroiwa Y
Muscle Nerve; 1995 Aug; 18(8):910-3. PubMed ID: 7630355
[No Abstract] [Full Text] [Related]
16. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of laminin beta 1 in chromosome 21-linked Bethlem myopathy.
Merlini L; Villanova M; Sabatelli P; Malandrini A; Maraldi NM
Neuromuscul Disord; 1999 Jul; 9(5):326-9. PubMed ID: 10407855
[TBL] [Abstract][Full Text] [Related]
18. Laminin beta 2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy).
Wewer UM; Durkin ME; Zhang X; Laursen H; Nielsen NH; Towfighi J; Engvall E; Albrechtsen R
Neurology; 1995 Nov; 45(11):2099-101. PubMed ID: 7501167
[TBL] [Abstract][Full Text] [Related]
19. Fukuyama-type congenital muscular dystrophy: close relation between changes in the muscle basal lamina and plasma membrane.
Matsubara S; Mizuno Y; Kitaguchi T; Isozaki E; Miyamoto K; Hirai S
Neuromuscul Disord; 1999 Oct; 9(6-7):388-98. PubMed ID: 10545042
[TBL] [Abstract][Full Text] [Related]
20. Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation.
Yamamoto T; Shibata N; Kanazawa M; Kobayashi M; Komori T; Ikeya K; Kondo E; Saito K; Osawa M
Acta Neuropathol; 1997 Aug; 94(2):173-9. PubMed ID: 9255393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
